GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for probable dual-specificity RNA methyltransferase rlmn (C0ZY23)

Analyse AlphaFold monomer V2.0 prediction for probable dual-specificity RNA… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
C0ZY23
Type
protein
Length
369 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x8E8D80fE94Dd5e533A2E21A78270Ddf47E8CB724
Molecule
Probable dual-specificity RNA methyltransferase rlmn
UniProt
C0ZY23
Pockets
4 · best druggability 0.77

Structure

1 distinct chain · 40% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProbable dual-specificity RNA methyltransferase rlmnprotein36940% helix, 19% strandC0ZY23

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14570.770.8559empty
2640.330.7614empty
3520.310.7612empty
4640.300.7416empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.